Sky News
@skynews·9.3M subscribers·76.1K videos
Alzheimer's: Early hopes for slowing the disease with Donanemab
Posted
July 17, 2023
Views
3,467
Likes
47
Comments
12
Engagement
1.70%
July 17, 2023
3,467
47
12
1.70%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
6:59Now PlayingA new drug has been hailed as a turning point in the fight against Alzheimer's disease.
Phase 3 clinical trials of Donanemab have shown that the drug can slow down cognitive decline by up to 35%, but only if the disease is detected early on in its course.
Questions remain though over whether the NHS can provide detection of the condition early enough to be effective, as Jessica Tobin from Alzheimer's Research UK told Sky News.
#alzheimer #dementia #treatment #breakthrough #mci
Read more here
SUBSCRIBE to our YouTube channel for more videos
Follow us on Twitter
Like us on Facebook
Follow us on Instagram
Follow us on TikTok
For more content go to and download our appsApple Android
Sky News Daily podcast is available for free here
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí
To enquire about licensing Sky News content, you can find more information here
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
